Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Adelstein

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Head & Neck|June 10, 2014
Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial designCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
Head & Neck|November 27, 2019
Impact of active smoking on outcomes in HPV+ oropharyngeal cancerRoy Xiao, Yvonne Pham, Matthew C Ward, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2017
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateArlene A Forastiere, Nofisat Ismaila, Jan S Lewin, et al.
Oral Oncology|October 10, 2020
Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 stagingKevin J Contrera, Timothy D Smile, Chengetai Mahomva, et al.
Journal of the National Cancer Institute|December 1, 2021
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal CancerGermán Corredor, Paula Toro, Can Koyuncu, et al.
Oral Oncology|February 20, 2022
Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative studyAhmed I Ghanem, Neil M Woody, Mathew A Schymick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2006
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer, David G Pfister, Scott A Laurie, et al.
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
International Journal of Radiation Oncology, Biology, Physics|March 13, 2026
Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trialJolie Ringash, Pedro A Torres-Saavedra, Maura L Gillison, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional CollaborationArslan Babar, Neil M Woody, Ahmed I Ghanem, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Head & Neck|June 10, 2014
Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial designCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
Head & Neck|November 27, 2019
Impact of active smoking on outcomes in HPV+ oropharyngeal cancerRoy Xiao, Yvonne Pham, Matthew C Ward, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2017
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateArlene A Forastiere, Nofisat Ismaila, Jan S Lewin, et al.
Oral Oncology|October 10, 2020
Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 stagingKevin J Contrera, Timothy D Smile, Chengetai Mahomva, et al.
Journal of the National Cancer Institute|December 1, 2021
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal CancerGermán Corredor, Paula Toro, Can Koyuncu, et al.
Oral Oncology|February 20, 2022
Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative studyAhmed I Ghanem, Neil M Woody, Mathew A Schymick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2006
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer, David G Pfister, Scott A Laurie, et al.
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
International Journal of Radiation Oncology, Biology, Physics|March 13, 2026
Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trialJolie Ringash, Pedro A Torres-Saavedra, Maura L Gillison, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional CollaborationArslan Babar, Neil M Woody, Ahmed I Ghanem, et al.
Pageof 11